“The study of genome mobility in oncogenic processes will revolutionise future diagnosis and treatment of cancer”
José Tubío has been part of the University of Vigo since 2016 and is one of the most important CINBIO researchers. With a background in Bioinformatics and Molecular Biology, he is a member of the International Cancer Genome Consortium and a recipient of an ERC Starting Grant. He currently leads the Mobile Genomics research group from which he coordinates research dealing with how certain sequences of DNA or tumour cells are mobilised and then cause the development of different types of cancer. Along with the Phylogenomics group led by David Posada, they set up the Evogenomics research group that currently has a team of around 20 people. 9 of the members from Evogenomics are part of the Mobile Genomics team. This multidisciplinary group is made up of bioinformaticians, mathematicians, pathologists, which provides a balance between the computational and the molecular biology areas.
The Master’s Degree programme is organized by the three universities in Galicia (NW Spain): University of Santiago de Compostela, University of A Coruña and University of Vigo.
The programme is characterized by being interdisciplinary and covers basic, applied and clinical aspects of neuroscience, as well as training in new technologies such as genomics and bioinformatics. The programme counts on the participation of a large number of researchers involved in the following fields: Cellular Neurobiology, Neurochemistry and Molecular Neurobiology, Neurogenetics, Neuroanatomy, Neurobiology of Development and Aging, Neurophysiology, Neuroendocrinology, Comparative Neurobiology, Neuropharmacology, Psychobiology, Cognitive Neuroscience, Neurobiology of Disease, Neuropsychiatry, Computational Neuroscience and Experimental Techniques in Neurobiology.
The paper was written by Dr. Jose Faro, who belongs to the Immunology Laboratory of CINBIO. They have demonstrated in the paper, that the TCR repertoires of Tfh and Tfr cells are actually very different from each other. This suggests the possibility that Tfh cells are antigen specific and Tfr cells are mainly self-reactive, an open question that remains to be proved.
The next 9th of May, will take place the conference “Reclasificación de las enfermedades autoinmunes sistémicas” by Dr. Marta Alarcón Riquelme (Centro Pfizer- Universidad de Granada – Junta de Andalucía de Genómica e Investigación Oncológica (GENYO). The conference will be at “Alvaro Cunqueiro” Hospital in Vigo.
Recently, Estela Magazine has published one article about CINBIO Neuroscience Laboratory and their work about the origin and development of diseases such as Parkinson, Alzheimer or ALS. This research is in cooperation with the University of Santiago de Compostela, the University of A Coruña and the Institute of Sanitary Research of Southern Galicia.
The commission publishes the resolution of the process CINBIO 17-18.